All Posts By

Smartkarma Daily Briefs

Daily Brief Thematic (Sector/Industry): Good Morning Japan |SPX Holds After Brutal Week; Solid Durable Goods; Japan Post $9bn X-Share Unwind and more

By | Daily Briefs, Thematic (Sector/Industry)

In today’s briefing:

  • Good Morning Japan |SPX Holds After Brutal Week; Solid Durable Goods; Japan Post $9bn X-Share Unwind
  • China Tourism and Hospitality Industry: A Year of Revenge
  • Macau Recovery: Window for Value Buys on Casino Stocks Beginning to Close
  • Crypto Mining Industry Series: Strong Start In 2023. Bitcoin Is Up ~40% YTD
  • Weekly Stock Bullfinder – Week of 2/27
  • China TMT Update(Feb.28):  700HK/SE/NTES/XPEV/9995HK – BYD Cut Prices for the Older Models

Good Morning Japan |SPX Holds After Brutal Week; Solid Durable Goods; Japan Post $9bn X-Share Unwind

By Mark Chadwick

  • OVERSEAS.  SPX Gains (barely) after a brutal week; Durable Goods Ex-Transport point to economic resilience;  Beta/Growth> Value as Cyclicals rebound; JPM Quant Sees $50bn Selling if SPX breeches 3940
  • JAPAN. NKY Futs +0.4% vs Cash; USDJPY 136.2; BOJ Gov Designate Ueda says no change to Easing for now; Japan Post Massive X-Share $9bn sale of Sub shares; Auto Upgrades
  • NUGGETS NUGGET. Nidec’s E-Axle Future may rest with the Europeans, not the Chinese !

China Tourism and Hospitality Industry: A Year of Revenge

By Osbert Tang, CFA

  • With re-opening of borders, China’s tourism and hospitality industry should see encouraging earnings outlook over the next two years; and we are now only in the early stage of recovery.  
  • Online travel agencies and hotel and resorts operators including Tongcheng Travel Holdings (780 HK), H World Group (1179 HK), Trip.com (9961 HK) and Fosun Tourism (1992 HK) are well positioned.
  • These companies all have sound business model, industry leadership position, solid competitive strengths, comprehensive customer coverage and, for some, meaningful global presence in their respective sub-sectors. 

Macau Recovery: Window for Value Buys on Casino Stocks Beginning to Close

By Howard J Klein

  • Macau GGR forecasts for 2023 continue to be revised upward.
  • Highest analyst call was for 2023 GGR of US$16b of baseline 2019. Morgan has now raised estimate to US$22b. Our call was US$18b.
  • Speedier build of premium mass and mass segments than anticipated before Beijing lifted zero covid is clearly ahead. Sector stocks not yet reflecting full price implications in our view.

Crypto Mining Industry Series: Strong Start In 2023. Bitcoin Is Up ~40% YTD

By Andrei Zakharov

  • Bitcoin could find the bottom and strongly rebounded in 1Q23. We believe BTC mining companies could be sellers of crypto assets on strong bounce and limit room for further upside. 
  • Our bear case scenario assumes an average BTC price of $25K in 2023 with an opportunity to reach as high as $30K. Leading crypto miners began to offload Bitcoin holdings. 
  • Investors should be more selective on the crypto miner names during a prolonged bear market. Our top picks include Marathon Digital Holdings, Riot Blockchain, and Cipher Mining. 

Weekly Stock Bullfinder – Week of 2/27

By Weekly Stock Bull Finder

  • After briefly dipping down to around 4.25%, last week saw a new cycle high for the closely followed 2 year Treasury yield breaking through the 4.8% level and ending the week at 4.814%.
  • This came off the back of continued unfavorably strong inflation and spending data from economic reports issued over the past few weeks (Core PCE, retail sales, GDP, PPI, etc.).
  • With the earnings yield on the S&P 500 is 4.68%, the equity risk premium on the S&P 500 (estimated earnings yield less 10yr treasury yield) is now the lowest since late 2007.

China TMT Update(Feb.28):  700HK/SE/NTES/XPEV/9995HK – BYD Cut Prices for the Older Models

By Shawn Yang

  • XPEV: BYD cut prices for the older models of its Dynasty series (-)
  • 700HK/SE/NTES: <Undawn> performance lower than expectation  (-/-/+), hence we cut our estimation of annual gross billings of the game
  • 9995HK: Daiichi Sangyo/Astra Zeneca’s ADC blockbuster DS8201 (Enhertu) approve by NMPA… Impact to Remegen is material in the long run (-)

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Technical Analysis: MicroStrategy Inc (MSTR US): 12.4% Profit Target Achieved in 5 Days and more

By | Daily Briefs, Technical Analysis

In today’s briefing:

  • MicroStrategy Inc (MSTR US): 12.4% Profit Target Achieved in 5 Days
  • Rio Tinto PLC (RIO LN) – 8.2% Profit Target at 5415/5650 Achieved in 3 Weeks
  • Hang Seng CEI (HSCEI) – Is Q1 2023 a Correction that Mirrors the Correction of Q1 2009?

MicroStrategy Inc (MSTR US): 12.4% Profit Target Achieved in 5 Days

By David Coloretti, CMT

  • TSS or “Trend Sustainability Score” is our proprietary momentum based tactical methodology. TSS has a proven record of identifying the exhaustion points in interim trends. 
  • On 17 February 2023 TSS identified exhaustion in the MSTR US uptrend and targeted a minimum 10% reversal in 1-2 weeks.
  • On 24 February 2023 MSTR US completed a 12.4% reversal from 284.03 to 248.87.

Rio Tinto PLC (RIO LN) – 8.2% Profit Target at 5415/5650 Achieved in 3 Weeks

By David Coloretti, CMT

  • At TMA we deliver high probability outcomes by focusing on our 3 pillars of technical analysis. •1) Response to key levels. •2) Price action. •3) Momentum confirmation.
  • On 3 February 2023 we identified a material topside failure in RIO LN and pending high probability multi-week to multi-month decline into the 5415/5650 range.
  • RIO LN declined from 6064 on 3 February to a low of 5568 on 27 February, a decline of 8.2%. Target achieved.

Hang Seng CEI (HSCEI) – Is Q1 2023 a Correction that Mirrors the Correction of Q1 2009?

By David Coloretti, CMT

  • At TMA we deliver high probability outcomes by focusing on our 3 pillars of technical analysis. •1) Response to key levels. •2) Price action. •3) Momentum confirmation.
  • The HSCEI has produced 2 material failures below 5000 in the last 17 years, in October 2008 and October 2022. Aggressive bullish multi-month reversals followed in both cases. 
  • The 2008 upswing paused when a bearish monthly reversal pattern was delivered in January 2009, but only for 2 months. The bearish monthly reversal pattern in February 2023 appears similar. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief ECM: Japan Post Bank (7182 JP) Announces Its Re-IPO – Big Offering and more

By | Daily Briefs, ECM

In today’s briefing:

  • Japan Post Bank (7182 JP) Announces Its Re-IPO – Big Offering, Complicated but Big Index Flows
  • Japan Post Bank Placement – Deal Structure, past Deals, Index, Buyback
  • Japan Post Bank (7182 JP): Japan Post Holdings to Sell Down a Third of Its Stake
  • Lu DaoPei Medical Group Pre-IPO – Ramp up in Progress but Looks Promising
  • UBTech Robotics Pre-IPO Tearsheet

Japan Post Bank (7182 JP) Announces Its Re-IPO – Big Offering, Complicated but Big Index Flows

By Travis Lundy

  • Japan Post Bank (7182 JP) has announced the mooted offering by Japan Post Holdings (6178 JP) whereby they will sell 29% of the bank to go from 89% to 60%.
  • There are two buybacks – one pre offering and one after – which is an attempt to mitigate impact. This creates interesting but complicated strategy possibilities. Lots of details here.
  • Big picture, this is a Very Big Offering at ¥1.236trln at today’s close including greenshoe. 80/20 dom/international. A TOUGH sell. 1.089bn shares is 4x current float. 

Japan Post Bank Placement – Deal Structure, past Deals, Index, Buyback

By Sumeet Singh


Japan Post Bank (7182 JP): Japan Post Holdings to Sell Down a Third of Its Stake

By Arun George

  • Japan Post Holdings (6178 JP)/JPH has announced the offering of up to 1.1 billion shares in Japan Post Bank (7182 JP)/JPB to reduce its stake from 89.00% to 59.95%.
  • JPB will carry out a ToSTNeT-3 buyback (maximum of JPY70 billion) and an on-market buyback (maximum of JPY80 billion). JPH can sell additional shares into the ToSTNeT-3 buyback.
  • For long-term investors, JPB’s forward P/B of 0.47x and yield of 4.41% are attractive to peers. JPB’s current price ratio is undemanding vs TOPIX Banks ETF and JPH.

Lu DaoPei Medical Group Pre-IPO – Ramp up in Progress but Looks Promising

By Ethan Aw

  • Lu Daopei Medical Group (1816743D CH) is looking to raise around US$400m in its upcoming Hong Kong IPO. 
  • Lu DaoPei Medical Group (LDPM) is a hospital operator focusing on hematology healthcare services. As per F&S, it was the largest hematology healthcare services provider in China by 2021 revenue.
  • LDPM has supported its growth through its flagship hospital. However, it is unclear whether the firm will be able to sustainably maintain profitability in the long term. 

UBTech Robotics Pre-IPO Tearsheet

By Ethan Aw

  • UBTech Robotics (1683374D HK) is looking to raise about US$700m in its upcoming HK IPO. The deal will be run by Guotai Junan.  
  • UBTech Robotics is engaged in artificial intelligence (AI)-empowered robotics in China, dedicated to the innovation of humanoid robots and development and sales of smart service robotic solutions. 
  • It has a full stack of proprietary robotic, AI and integrated robotic and AI technologies for application in a range of enterprise-level and consumer-level use scenarios across various sectors.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Equity Bottom-Up: Grab (GRAB US) – Moving Towards Steady State and more

By | Daily Briefs, Equity Bottom-Up

In today’s briefing:

  • Grab (GRAB US) – Moving Towards Steady State
  • [Alibaba (BABA US) Target Price Change]: Cut TP for Intensified Competition in ECommerce
  • Raffles Medical: Consensus Too Conservative and Warrants an Upgrade
  • Softbank (9984 JP): Focus on Vision Fund II (SVF2) And Masa’s Massive IOUs
  • Kalbe Farma (KLBF IJ) – More Innovation and Digitalization in 2023
  • Pinduoduo: Entering the Big League
  • [Baidu (BIDU US) Target Price Change]: Margin Improvement Offsets R&D Increase
  • Edelweiss: Wealth Management Arm Demerger Is Nearing
  • Raffles Medical (RFMD SP): 2022 Result Tops Expectation; Medical Tourism Resumption to Drive Growth
  • Chinese Regulators Question Auto Supplier Over Next-Generation Battery Claims

Grab (GRAB US) – Moving Towards Steady State

By Angus Mackintosh

  • Grab Holdings (GRAB US) 4Q2022 numbers late last week made encouraging reading with revenues exceeding expectations significantly despite slow GMV growth in the quarter, as it maintained regional category leadership.
  • The company saw continued improvement in segment-adjusted EBITDA margins in 4Q2022 versus 3Q2022 for both mobility and deliveries, with the latter making significant progress towards steady-state margins. 
  • Grab‘s relatively high regional cost remains a drag but should stabilise here and outside this, it looks to be firmly on track to accelerate profitably. 

[Alibaba (BABA US) Target Price Change]: Cut TP for Intensified Competition in ECommerce

By Shawn Yang

  • BABA reported F3Q23 (C4Q22) total revenue largely in line with our est. and cons. Non-GAAP net profit beat our est. and cons. by 5% and 13% YoY.
  • Taobao will face pricing pressure against JD and PDD. We expect BABA to focus on user content, which leads to improvement in app time spent and advertising. 
  • We cut TP from US$130 to US$110 to reflect intensified competition in eCommerce. Maintain BUY rating due to recovery in CMR and international retail, and rebound in cloud business. 

Raffles Medical: Consensus Too Conservative and Warrants an Upgrade

By Shifara Samsudeen, ACMA, CGMA

  • Raffles Medical reported 2H2022 and full-year 2022 results today. Full-year revenue increased 5.9% YoY to SG$766.5m (vs consensus $774.7m) and OP increased 61.4% YoY to $195.8m (vs consensus $170m).
  • Despite Covid-19 related revenues tapering off and China under lockdown during 2H2022, Raffles’ earnings saw a boost from Singapore reopening borders and recovery in foreign patient volume.
  • Consensus forecasts are too conservative and does not reflect the recovery in demand for Raffles’ healthcare services in Singapore and China (post reversing of zero-Covid policy).

Softbank (9984 JP): Focus on Vision Fund II (SVF2) And Masa’s Massive IOUs

By Victor Galliano

  • Vision Fund II private companies accounted for 87% of the fund’s 3QFY22 fair value; versus investment cost, private companies’ downward valuation revisions have been more modest than the public companies
  • Vision Fund II accounted for 22% of the group’s 3QFY22 equity value of holdings, so any further downward valuation revisions would hurt group NAV and add to Masa’s Softbank liabilities
  • Softbank currently trades at a 42% discount to its stated NAV; we believe that the stated NAV is likely to be overstated, with private company valuations needing further scrutiny

Kalbe Farma (KLBF IJ) – More Innovation and Digitalization in 2023

By Angus Mackintosh

  • Kalbe Farma (KLBF IJ) revealed an indicative set of 2022 numbers, which fell slightly short of estimates due to product mix changes and inflationary pressure from higher input costs.
  • Management guidance for 2023 looks more positive and implies stable margins in the coming year, with strong momentum across prescription drugs, consumer health, nutritionals, and logistics and less inflationary pressure.
  • Kalbe Farma looks interesting with more positive expectations for earnings growth in 2023, coupled with valuations below its 5-year average forward PER.

Pinduoduo: Entering the Big League

By Steven Holden

  • Investor interest in Pinduoduo (PDD US)  has surged, hitting record-high levels of fund ownership this month.
  • Over the period from the recent lows in March 2022 to today, Pinduoduo’s +20% increase in the percentage of funds invested was the highest across all stocks in China.
  • New positions from JSS All China (+7.49%) and Tamaq China Champions (+4.99%) were complemented by increased weights from China Fund (+5.35%) and GAM China Evolution (+5.26%).

[Baidu (BIDU US) Target Price Change]: Margin Improvement Offsets R&D Increase

By Shawn Yang

  • Baidu delivered 4Q22 results with top line beating cons. by 3.2% and non-GAAP net income beating cons. by 13.4%. 
  • We expect both its ads and AI cloud businesses to recover with accelerated pace, which could partially offset the increase of R&D investment in AI related technologies.
  • Reiterate BUY rating and slightly raise TP to US$ 172 to reflect the on-track recovery and AIGC synergy. Our TP implies 17.9x PE in 2023.

Edelweiss: Wealth Management Arm Demerger Is Nearing

By Ankit Agrawal, CFA

  • A key re-rating trigger for Edelweiss’ stock is nearing as its wealth management (WM) arm gets close to demerge and list over the next couple of months.
  • Edelweiss’ WM business could list at a market cap of around INR 8750cr, suggesting that Edelweiss’ 44% stake in it alone could be valued at INR 3850cr.
  • Edelweiss also reported strong Q3FY23 earnings with 31% YoY growth in ex-insurance PAT. Edelweiss has significant potential to re-rate over the next couple of years as the credit business normalizes.

Raffles Medical (RFMD SP): 2022 Result Tops Expectation; Medical Tourism Resumption to Drive Growth

By Tina Banerjee

  • Raffles Medical (RFMD SP) reported strong 2022 results, with 6% growth in revenue and 71% increase in net profit. Growth was driven by healthcare services, which contributed 58% of revenue.
  • With the reopening of borders and easing of COVID-19 related protocols in H2 2022, RMG saw a return of foreign patients seeking medical treatment in Singapore.
  • In view of the company’s strong performance, the Board recommended a dividend of 3.8 cents/share for 2022, representing an increase of 36% as compared to the previous year.

Chinese Regulators Question Auto Supplier Over Next-Generation Battery Claims

By Caixin Global

  • China’s securities regulator is investigating auto component supplier Nanjing Aolian AE&EA Co. Ltd. (300585.SZ -3.76%) after its stock price fell more than 30% this week when questions arose about its expertise in a key solar panel technology. 
  • The China Securities Regulatory Commission (CSRC) has started scrutinizing the firm on suspicion of providing false information to the public about its new business, according to a note that Nanjing Aolian received Thursday night.
  • The investigation added to doubts about the company’s expertise in perovskite batteries at a time when it is defending itself from a separate regulatory inquiry into whether it took advantage of market interest in the technology to inflate its stock price.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Event-Driven: Japan Post Bank (7182 JP): BIG Offering Supported by Buybacks & Passive Flow and more

By | Daily Briefs, Event-Driven

In today’s briefing:

  • Japan Post Bank (7182 JP): BIG Offering Supported by Buybacks & Passive Flow
  • PCCW And HKT’s 2022 Results
  • Shorting Entry Point on Ecopro BM with KODEX Battery ETF Rebalancing on March 10
  • Slater & Gordon (SGH AU): Allegro’s Opening Salvo
  • Quiddity Leaderboard JPX-Nikkei 400: End-Feb 2023
  • EQD | SPX Vs SX5E: Trade a Relative Value Vol Spread
  • G.K.Goh’s Voluntary MBO

Japan Post Bank (7182 JP): BIG Offering Supported by Buybacks & Passive Flow

By Brian Freitas

  • Japan Post Holdings (6178 JP) is looking to reduce its stake in Japan Post Bank (7182 JP) from 89% to 60%. That is over US$9bn at the last close.
  • The placement is supported by buybacks (ToSTNeT-3 and on-market) that will absorb some of the offering. Then there is the passive buying that will absorb a third of the offering. 
  • One of the key short-term supports will be the exercise of the over-allotment of the Japan offering. But that will require persuading retail investors to buy into the offering.

PCCW And HKT’s 2022 Results

By David Blennerhassett

  • PCCW Ltd (8 HK)‘s FY22 revenue, EBITDA, and profit increased by 2%, 6%, and 11% to HK$36.1bn,  HK$12.4bn, and HK$834mn.
  • HKT Ltd (6823 HK)‘s revenue, EBITDA, and profit increased by 0.5%, 3%, and 0.4% to HK$34.1bn,  HK$13.1bn, and HK$4.7mn.
  • The dividend pass-through is 100%. PCCW’s current discount to NAV is in line with its 52-week average.

Shorting Entry Point on Ecopro BM with KODEX Battery ETF Rebalancing on March 10

By Sanghyun Park

  • Ecopro BM’s weight has expanded to 22%. Since the probability of receiving a 15% cap is virtually 100%, it will inevitably undergo a weight change of up to nearly 7%p.
  • If the ongoing rally subsides before March 10th and returns to the January DTV level, the price impact could surge up to 0.3-0.4x daily for three trading days.
  • This seems to be a sufficient level for a shorting entry point. It may be worth considering an outright short position on Ecopro BM or Long Short with SK Innovation.

Slater & Gordon (SGH AU): Allegro’s Opening Salvo

By David Blennerhassett

  • Beleaguered law firm Slater & Gordon (SGH AU) has announced an A$0.55/share cash off-market Offer from Aussie PE outfit Allegro.  
  • The key condition is Allegro acquiring a a 50.1% interest. This condition may be waived. 
  • The Offer was more than welcome by S&G’s board. “We don’t belong on the stock exchange,” said  CEO John Somerville.

Quiddity Leaderboard JPX-Nikkei 400: End-Feb 2023

By Janaghan Jeyakumar, CFA

  • JPX-Nikkei 400 is composed of common stocks listed on the Tokyo Stock Exchange. It is a free-float-adjusted market-value-weighted (capped) index composed of 400 constituents.
  • A periodic review is conducted by the Index providers, the JPX Group and Nikkei Inc, in August every year. We look at the potential forward inclusions and removals every month.
  • Below is a look at potential Inclusions and Removals for the JPX-Nikkei 400 Rebalance to come in August 2023 based on trading data as of end-February 2023.

EQD | SPX Vs SX5E: Trade a Relative Value Vol Spread

By Simon Harris

  • European markets have begun to outperform their US peers over last few months
  • The differences in market sentiment have driven both the implied and realised vol spread wider 
  • Trade a relative vol spread that should hold up in multiple market scenarios

G.K.Goh’s Voluntary MBO

By David Blennerhassett

  • Verveine Pte. Ltd., a vehicle controlled by Goh Geok Khim (executive chairman) and Goh Yew Lin (MD), has made a voluntary offer for GK Goh Holdings (GKG SP).
  • The Offer price of $1.26/share, which is final, is a 38.5% premium to last close.  It is conditional on the Gohs holding 90%, which may be reduced to 50%.
  • GKG Investment, with 62.89%, has given an irrevocable to tender. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Industrials: S&P 500, Schneider Electric Infrastructure, Cie De Saint-Gobain, HNI Corp, Kimball International B, UBTech Robotics and more

By | Daily Briefs, Industrials

In today’s briefing:

  • EQD | SPX Vs SX5E: Trade a Relative Value Vol Spread
  • Schneider Electric Infra Ltd (SEIL)- Forensic Analysis
  • Cie De Saint-Gobain: +17% Since Our Initial Note. Fantastic Results Confirm Our Bull Case.
  • Margin Improvement Evident in 4Q22; Sales Headwinds Remain into 2023
  • Kimball International, Inc. (Nasdaq: Kbal) – Initiating Coverage
  • UBTech Robotics Pre-IPO Tearsheet

EQD | SPX Vs SX5E: Trade a Relative Value Vol Spread

By Simon Harris

  • European markets have begun to outperform their US peers over last few months
  • The differences in market sentiment have driven both the implied and realised vol spread wider 
  • Trade a relative vol spread that should hold up in multiple market scenarios

Schneider Electric Infra Ltd (SEIL)- Forensic Analysis

By Nitin Mangal

  • Schneider Electric Infrastructure (SCHN IN) is engaged in manufacturing of products and systems for electricity distribution, such as distribution transformers, medium voltage switchgears, etc.
  • After plagued with losses for most of last decade, the company has entered into positive net worth and profit territory. 
  • However, forensics do indicate concerns on aspects such as borrowing rates, inventory verification, contingent liability, etc. including few governance woes.

Cie De Saint-Gobain: +17% Since Our Initial Note. Fantastic Results Confirm Our Bull Case.

By Alexis Dwek

  • All financial performance indicators at a record high in 2022 (growth, operating income, margin, recurring net income, free cash flow, ROCE)
  • Transformation going according to plan, group’s profile towards fast-growing markets
  • Valuation remains cheap on our model – still upside from here. TP: €72

Margin Improvement Evident in 4Q22; Sales Headwinds Remain into 2023

By Water Tower Research

  • Before market open on February 23, HNI reported 4Q22 results that were better than we expected on both the top line (a modest beat) and margins (a significant beat).
  • Results were also ahead of consensus. HNI reported 4Q22 sales of $569 million versus $603 million in 4Q21, ahead of our estimate by $7.5 million and consensus by $9 million.
  • Adjusted EPS was $0.63, or $0.17 ahead of our estimate of $0.46 (also consensus).

Kimball International, Inc. (Nasdaq: Kbal) – Initiating Coverage

By Water Tower Research

  • We are initiating research coverage of Kimball International. For shareholders and potential investors, Kimball’s relevant history began in 1949 when Arnold Habig led the acquisition and reorganization of Midwest Manufacturing, a struggling manufacturer based in Jasper, Indiana.
  • Kimball management initiated its current strategy in 2014, focusing exclusively on commercial furniture.
  • Its strategy differs from other commercial furniture manufacturers by emphasizing ancillary products (88% of TTM revenues as of 2Q23) and concentrating on secondary geographic markets (79% of TTM revenues as of 2Q23).

UBTech Robotics Pre-IPO Tearsheet

By Ethan Aw

  • UBTech Robotics (1683374D HK) is looking to raise about US$700m in its upcoming HK IPO. The deal will be run by Guotai Junan.  
  • UBTech Robotics is engaged in artificial intelligence (AI)-empowered robotics in China, dedicated to the innovation of humanoid robots and development and sales of smart service robotic solutions. 
  • It has a full stack of proprietary robotic, AI and integrated robotic and AI technologies for application in a range of enterprise-level and consumer-level use scenarios across various sectors.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief TMT/Internet: Grab Holdings, PCCW Ltd, Alibaba (ADR), Softbank Group, Baidu, NetEase Inc, Meituan, Alphabet Inc Cl C, Taiwan Semiconductor (TSMC) – ADR, IceKredit and more

By | Daily Briefs, TMT/Internet

In today’s briefing:

  • Grab (GRAB US) – Moving Towards Steady State
  • PCCW And HKT’s 2022 Results
  • [Alibaba (BABA US) Target Price Change]: Cut TP for Intensified Competition in ECommerce
  • Softbank (9984 JP): Focus on Vision Fund II (SVF2) And Masa’s Massive IOUs
  • [Baidu (BIDU US) Target Price Change]: Margin Improvement Offsets R&D Increase
  • [NetEase (NTES US) Earnings Review]: Eggy Party and Justice Mobile Are Two Catalysts
  • Meituan Gears Up for Hong Kong Expansion With Rider Recruitment
  • Google Stock Could Be Losing Its Moat
  • Taiwan Tech Weekly: U.S. Pushing South Korea China Restrictions, Nanya Says Memory Bottom in 1Q23E
  • Chinese Fintech Firm IceKredit Gears up for SEA Expansion

Grab (GRAB US) – Moving Towards Steady State

By Angus Mackintosh

  • Grab Holdings (GRAB US) 4Q2022 numbers late last week made encouraging reading with revenues exceeding expectations significantly despite slow GMV growth in the quarter, as it maintained regional category leadership.
  • The company saw continued improvement in segment-adjusted EBITDA margins in 4Q2022 versus 3Q2022 for both mobility and deliveries, with the latter making significant progress towards steady-state margins. 
  • Grab‘s relatively high regional cost remains a drag but should stabilise here and outside this, it looks to be firmly on track to accelerate profitably. 

PCCW And HKT’s 2022 Results

By David Blennerhassett

  • PCCW Ltd (8 HK)‘s FY22 revenue, EBITDA, and profit increased by 2%, 6%, and 11% to HK$36.1bn,  HK$12.4bn, and HK$834mn.
  • HKT Ltd (6823 HK)‘s revenue, EBITDA, and profit increased by 0.5%, 3%, and 0.4% to HK$34.1bn,  HK$13.1bn, and HK$4.7mn.
  • The dividend pass-through is 100%. PCCW’s current discount to NAV is in line with its 52-week average.

[Alibaba (BABA US) Target Price Change]: Cut TP for Intensified Competition in ECommerce

By Shawn Yang

  • BABA reported F3Q23 (C4Q22) total revenue largely in line with our est. and cons. Non-GAAP net profit beat our est. and cons. by 5% and 13% YoY.
  • Taobao will face pricing pressure against JD and PDD. We expect BABA to focus on user content, which leads to improvement in app time spent and advertising. 
  • We cut TP from US$130 to US$110 to reflect intensified competition in eCommerce. Maintain BUY rating due to recovery in CMR and international retail, and rebound in cloud business. 

Softbank (9984 JP): Focus on Vision Fund II (SVF2) And Masa’s Massive IOUs

By Victor Galliano

  • Vision Fund II private companies accounted for 87% of the fund’s 3QFY22 fair value; versus investment cost, private companies’ downward valuation revisions have been more modest than the public companies
  • Vision Fund II accounted for 22% of the group’s 3QFY22 equity value of holdings, so any further downward valuation revisions would hurt group NAV and add to Masa’s Softbank liabilities
  • Softbank currently trades at a 42% discount to its stated NAV; we believe that the stated NAV is likely to be overstated, with private company valuations needing further scrutiny

[Baidu (BIDU US) Target Price Change]: Margin Improvement Offsets R&D Increase

By Shawn Yang

  • Baidu delivered 4Q22 results with top line beating cons. by 3.2% and non-GAAP net income beating cons. by 13.4%. 
  • We expect both its ads and AI cloud businesses to recover with accelerated pace, which could partially offset the increase of R&D investment in AI related technologies.
  • Reiterate BUY rating and slightly raise TP to US$ 172 to reflect the on-track recovery and AIGC synergy. Our TP implies 17.9x PE in 2023.

[NetEase (NTES US) Earnings Review]: Eggy Party and Justice Mobile Are Two Catalysts

By Shawn Yang

  • NetEase’s 4Q22 revenue was in-line with cons., while its non-GAAP net income missed cons. by (8%) because of a one-off, non-renewal contract with Blizzard.
  • We still see NetEase as a BUY because of <Eggy Party>’s overseas publishing and <Justice Mobile>, which we estimate will contribute about 1-2bn/3-4bn RMB for annual gross billing, respectively. 
  • We maintain BUY and TP US$ 87, which implies 16.0X PE in 2023.

Meituan Gears Up for Hong Kong Expansion With Rider Recruitment

By Caixin Global

  • Chinese food delivery giant Meituan launched a recruitment campaign in Hong Kong signaling a push into the Asian financial hub dominated by foreign on-demand service leaders foodpanda and Deliveroo.
  • Meituan is hiring delivery workers including motorcycle and bike riders as well as so-called foot soldiers who can dispatch orders by foot, a recruitment document showed.
  • As an incentive, Meituan said new riders who complete a certain volume of orders will receive a bonus of HK$2,500 ($319).

Google Stock Could Be Losing Its Moat

By Kevin George

  • Microsoft is improving its search market share, according to analysts.
  • The arrival of ChatGPT hammered Alphabet stock may be ahead as revenue effects sink in, says analyst.
  • The company is also improving its market share and improving its search market share.

Taiwan Tech Weekly: U.S. Pushing South Korea China Restrictions, Nanya Says Memory Bottom in 1Q23E

By Vincent Fernando, CFA

  • The U.S. is reportedly working to implement China semiconductor restrictions with South Korean firms, after doing the same with Japanese and Dutch firms.
  • Nanya management sees a bottom for Memory prices in 1Q23E; we look at Long Micron vs. Short Nanya.
  • Firms are significantly expanding semiconductor capacity in Singapore, with the latest being Applied Materials and French firm Soitec.

Chinese Fintech Firm IceKredit Gears up for SEA Expansion

By Tech in Asia

  • IceKredit, a Chinese AI-focused credit risk and management company, plans to export its AI-powered products and solutions to financial institutions in Southeast Asia.
  • Founded in 2015, IceKredit helps lenders to establish an automated end-to-end digital lending process – from application pre-screening to collections – by providing risk mitigation products and services.
  • In the past two years, the firm has raised over US$58 million in series C funding, a large part of which will be used for its Southeast Asian expansion, the company says.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Energy/Materials: Ecopro BM Co Ltd, Rio Tinto PLC, Franco-Nevada Corp, Kingston Resources, Primary Gold, Rent.com.au Ltd, Southern Cross Gold, Flotek Industries and more

By | Daily Briefs, Energy & Materials Sector

In today’s briefing:

  • Shorting Entry Point on Ecopro BM with KODEX Battery ETF Rebalancing on March 10
  • Rio Tinto PLC (RIO LN) – 8.2% Profit Target at 5415/5650 Achieved in 3 Weeks
  • The Importance of Asymmetry
  • Kingston Resources Limited – Building a Production Base
  • Pacgold Ltd – Seeking to Unlock an Entire Gold Corridor, at Scale
  • Rent.com.au Ltd – RentPay Making Good Progress with ARPU and Customers
  • Southern Cross Gold Ltd – Leading the Renaissance in the Victorian Goldfields
  • Contract Backlog Supports 2023 Revenue Outlook

Shorting Entry Point on Ecopro BM with KODEX Battery ETF Rebalancing on March 10

By Sanghyun Park

  • Ecopro BM’s weight has expanded to 22%. Since the probability of receiving a 15% cap is virtually 100%, it will inevitably undergo a weight change of up to nearly 7%p.
  • If the ongoing rally subsides before March 10th and returns to the January DTV level, the price impact could surge up to 0.3-0.4x daily for three trading days.
  • This seems to be a sufficient level for a shorting entry point. It may be worth considering an outright short position on Ecopro BM or Long Short with SK Innovation.

Rio Tinto PLC (RIO LN) – 8.2% Profit Target at 5415/5650 Achieved in 3 Weeks

By David Coloretti, CMT

  • At TMA we deliver high probability outcomes by focusing on our 3 pillars of technical analysis. •1) Response to key levels. •2) Price action. •3) Momentum confirmation.
  • On 3 February 2023 we identified a material topside failure in RIO LN and pending high probability multi-week to multi-month decline into the 5415/5650 range.
  • RIO LN declined from 6064 on 3 February to a low of 5568 on 27 February, a decline of 8.2%. Target achieved.

The Importance of Asymmetry

By MT Capital

  • In theory, the fundamental building blocks of the universe, matter and anti-matter, should exist at a 1:1 ratio, a positron for every electron, a yin to each yang.
  • However, owed to some miraculous flaw in the simulation’s code, a perturbation in the motion of the universe’s marionette, this is not the case.
  • Rather than the big-bang resulting in the almost immediate annihilation of matter and anti-matter into photons, matter prevailed, surviving in excess to its counterpart.

Kingston Resources Limited – Building a Production Base

By Research as a Service (RaaS)

  • Kingston Resources Limited (ASX:KSN) is an ASX-listed gold and copper mining company with two significant projects at Mineral Hill (Cobar, NSW), where the tailings production project is delivering record quarterly results, and the 3.8Moz Misima Gold Project in PNG, with a recently completed DFS.
  • The tailings project at Mineral Hill is a precursor to the company’s aim to return to full-scale mining through building the reserves and resources base during 2023.
  • The company expects to commence open-pit operations at the Pearse deposits in early 2024, progressing to underground works and first copper in late 2024 from the Southern Ore Zone.

Pacgold Ltd – Seeking to Unlock an Entire Gold Corridor, at Scale

By Research as a Service (RaaS)

  • Pacgold Limited (ASX:PGO) is an ASX-listed minerals exploration company focused on the Alice River gold project at the northern end of the North-east Queensland Mineral Province.
  • Pacgold has a 100% interest in Alice River, covering an historical high-grade goldfield and open-pit mine with eight mining leases and five exploration permits over an area spanning 377km2.
  • The company commences drilling in March/April with a pipeline of high-grade targets along a previously overlooked 30km trend.

Rent.com.au Ltd – RentPay Making Good Progress with ARPU and Customers

By Research as a Service (RaaS)

  • Rent.com.au Limited (ASX:RNT) is a purpose-led company seeking to empower home renters through their technology platform and a growing number of aligned transactional services.
  • The company has reported H1 FY23 revenue of $1.43m, down 12.6% on the previous corresponding period (pcp) and below our forecast for $1.95m for the half.
  • Underlying EBITDA was a loss of $1.0m, compared with $0.82m in H1 FY22. The EPS loss for the period was flat year on year. 

Southern Cross Gold Ltd – Leading the Renaissance in the Victorian Goldfields

By Research as a Service (RaaS)

  • Southern Cross Gold Ltd (ASX:SXG) is an ASX-listed gold and critical metals company with three projects in the Victorian goldfields and one in Mt Isa, Queensland.
  • The company’s flagship project Sunday Creek is an epizonal gold-antimony deposit with antimony a critical metal used across the semi-conductor, defence and energy sector, in particular in lithium ion battery production.
  • SXG listed on the ASX in May 2022 after raising $9.093mn at $0.20/share in an initial public offering to give a market capitalisation at listing of $31.25mn. 

Contract Backlog Supports 2023 Revenue Outlook

By Water Tower Research

  • We expect the steep revenue ramp, which commenced in 2Q22, to continue into 2023 as Flotek continues to expand service to a growing number of ProFrac’s pressure pumping fleets to meet the terms of the 10-year supply agreement signed in February 2022.
  • Flotek will supply the greater of 70% of ProFrac’s stimulation chemistry requirements or 30 frac fleets. For its part, ProFrac expects to have up to 49 active fleets by mid-year 2023.
  • We have built a 2023 reported revenue estimate of ~$224 million based on supplying an average of 26 ProFrac crews.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars
Raffles Medical Share Price: A Comprehensive Guide to Investing in One of Singapore's Top Healthcare Stocks

Daily Brief Health Care: Raffles Medical, Kalbe Farma, Nakanishi Inc, Lu Daopei Medical Group, Keymed Biosciences and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • Raffles Medical: Consensus Too Conservative and Warrants an Upgrade
  • Kalbe Farma (KLBF IJ) – More Innovation and Digitalization in 2023
  • Quiddity Leaderboard JPX-Nikkei 400: End-Feb 2023
  • Raffles Medical (RFMD SP): 2022 Result Tops Expectation; Medical Tourism Resumption to Drive Growth
  • Lu DaoPei Medical Group Pre-IPO – Ramp up in Progress but Looks Promising
  • Keymed Biosciences (2162.HK) – The $1.2B Deal with AstraZeneca for ADC and the Logic Behind

Raffles Medical: Consensus Too Conservative and Warrants an Upgrade

By Shifara Samsudeen, ACMA, CGMA

  • Raffles Medical reported 2H2022 and full-year 2022 results today. Full-year revenue increased 5.9% YoY to SG$766.5m (vs consensus $774.7m) and OP increased 61.4% YoY to $195.8m (vs consensus $170m).
  • Despite Covid-19 related revenues tapering off and China under lockdown during 2H2022, Raffles’ earnings saw a boost from Singapore reopening borders and recovery in foreign patient volume.
  • Consensus forecasts are too conservative and does not reflect the recovery in demand for Raffles’ healthcare services in Singapore and China (post reversing of zero-Covid policy).

Kalbe Farma (KLBF IJ) – More Innovation and Digitalization in 2023

By Angus Mackintosh

  • Kalbe Farma (KLBF IJ) revealed an indicative set of 2022 numbers, which fell slightly short of estimates due to product mix changes and inflationary pressure from higher input costs.
  • Management guidance for 2023 looks more positive and implies stable margins in the coming year, with strong momentum across prescription drugs, consumer health, nutritionals, and logistics and less inflationary pressure.
  • Kalbe Farma looks interesting with more positive expectations for earnings growth in 2023, coupled with valuations below its 5-year average forward PER.

Quiddity Leaderboard JPX-Nikkei 400: End-Feb 2023

By Janaghan Jeyakumar, CFA

  • JPX-Nikkei 400 is composed of common stocks listed on the Tokyo Stock Exchange. It is a free-float-adjusted market-value-weighted (capped) index composed of 400 constituents.
  • A periodic review is conducted by the Index providers, the JPX Group and Nikkei Inc, in August every year. We look at the potential forward inclusions and removals every month.
  • Below is a look at potential Inclusions and Removals for the JPX-Nikkei 400 Rebalance to come in August 2023 based on trading data as of end-February 2023.

Raffles Medical (RFMD SP): 2022 Result Tops Expectation; Medical Tourism Resumption to Drive Growth

By Tina Banerjee

  • Raffles Medical (RFMD SP) reported strong 2022 results, with 6% growth in revenue and 71% increase in net profit. Growth was driven by healthcare services, which contributed 58% of revenue.
  • With the reopening of borders and easing of COVID-19 related protocols in H2 2022, RMG saw a return of foreign patients seeking medical treatment in Singapore.
  • In view of the company’s strong performance, the Board recommended a dividend of 3.8 cents/share for 2022, representing an increase of 36% as compared to the previous year.

Lu DaoPei Medical Group Pre-IPO – Ramp up in Progress but Looks Promising

By Ethan Aw

  • Lu Daopei Medical Group (1816743D CH) is looking to raise around US$400m in its upcoming Hong Kong IPO. 
  • Lu DaoPei Medical Group (LDPM) is a hospital operator focusing on hematology healthcare services. As per F&S, it was the largest hematology healthcare services provider in China by 2021 revenue.
  • LDPM has supported its growth through its flagship hospital. However, it is unclear whether the firm will be able to sustainably maintain profitability in the long term. 

Keymed Biosciences (2162.HK) – The $1.2B Deal with AstraZeneca for ADC and the Logic Behind

By Xinyao (Criss) Wang

  • It’s “a wise decision” to out-license CMG901 and receive cashflow in advance so as to focus on more important late-stage products.Keymed’s management is as pragmatic as ever in strategic choices.
  • Biotech would find it difficult to promote products by themselves and has to cooperate with Big Pharma to open domestic/foreign markets. But many investors are still “living in the illusion”.
  • There would be more BD deals in the future. Our view on Keymed’s valuation remains unchanged – Market cap about RMB8 billion to RMB1.6 billion is the reasonable range. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Financials: Japan Post Bank, Edelweiss Financial Services, GK Goh Holdings, Hang Seng China Enterprises Index, Regional REIT Ltd and more

By | Daily Briefs, Financials

In today’s briefing:

  • Japan Post Bank (7182 JP) Announces Its Re-IPO – Big Offering, Complicated but Big Index Flows
  • Japan Post Bank Placement – Deal Structure, past Deals, Index, Buyback
  • Japan Post Bank (7182 JP): BIG Offering Supported by Buybacks & Passive Flow
  • Japan Post Bank (7182 JP): Japan Post Holdings to Sell Down a Third of Its Stake
  • Edelweiss: Wealth Management Arm Demerger Is Nearing
  • G.K.Goh’s Voluntary MBO
  • Hang Seng CEI (HSCEI) – Is Q1 2023 a Correction that Mirrors the Correction of Q1 2009?
  • Regional REIT – FY22 DPS covered and yields c 11% yield

Japan Post Bank (7182 JP) Announces Its Re-IPO – Big Offering, Complicated but Big Index Flows

By Travis Lundy

  • Japan Post Bank (7182 JP) has announced the mooted offering by Japan Post Holdings (6178 JP) whereby they will sell 29% of the bank to go from 89% to 60%.
  • There are two buybacks – one pre offering and one after – which is an attempt to mitigate impact. This creates interesting but complicated strategy possibilities. Lots of details here.
  • Big picture, this is a Very Big Offering at ¥1.236trln at today’s close including greenshoe. 80/20 dom/international. A TOUGH sell. 1.089bn shares is 4x current float. 

Japan Post Bank Placement – Deal Structure, past Deals, Index, Buyback

By Sumeet Singh


Japan Post Bank (7182 JP): BIG Offering Supported by Buybacks & Passive Flow

By Brian Freitas

  • Japan Post Holdings (6178 JP) is looking to reduce its stake in Japan Post Bank (7182 JP) from 89% to 60%. That is over US$9bn at the last close.
  • The placement is supported by buybacks (ToSTNeT-3 and on-market) that will absorb some of the offering. Then there is the passive buying that will absorb a third of the offering. 
  • One of the key short-term supports will be the exercise of the over-allotment of the Japan offering. But that will require persuading retail investors to buy into the offering.

Japan Post Bank (7182 JP): Japan Post Holdings to Sell Down a Third of Its Stake

By Arun George

  • Japan Post Holdings (6178 JP)/JPH has announced the offering of up to 1.1 billion shares in Japan Post Bank (7182 JP)/JPB to reduce its stake from 89.00% to 59.95%.
  • JPB will carry out a ToSTNeT-3 buyback (maximum of JPY70 billion) and an on-market buyback (maximum of JPY80 billion). JPH can sell additional shares into the ToSTNeT-3 buyback.
  • For long-term investors, JPB’s forward P/B of 0.47x and yield of 4.41% are attractive to peers. JPB’s current price ratio is undemanding vs TOPIX Banks ETF and JPH.

Edelweiss: Wealth Management Arm Demerger Is Nearing

By Ankit Agrawal, CFA

  • A key re-rating trigger for Edelweiss’ stock is nearing as its wealth management (WM) arm gets close to demerge and list over the next couple of months.
  • Edelweiss’ WM business could list at a market cap of around INR 8750cr, suggesting that Edelweiss’ 44% stake in it alone could be valued at INR 3850cr.
  • Edelweiss also reported strong Q3FY23 earnings with 31% YoY growth in ex-insurance PAT. Edelweiss has significant potential to re-rate over the next couple of years as the credit business normalizes.

G.K.Goh’s Voluntary MBO

By David Blennerhassett

  • Verveine Pte. Ltd., a vehicle controlled by Goh Geok Khim (executive chairman) and Goh Yew Lin (MD), has made a voluntary offer for GK Goh Holdings (GKG SP).
  • The Offer price of $1.26/share, which is final, is a 38.5% premium to last close.  It is conditional on the Gohs holding 90%, which may be reduced to 50%.
  • GKG Investment, with 62.89%, has given an irrevocable to tender. 

Hang Seng CEI (HSCEI) – Is Q1 2023 a Correction that Mirrors the Correction of Q1 2009?

By David Coloretti, CMT

  • At TMA we deliver high probability outcomes by focusing on our 3 pillars of technical analysis. •1) Response to key levels. •2) Price action. •3) Momentum confirmation.
  • The HSCEI has produced 2 material failures below 5000 in the last 17 years, in October 2008 and October 2022. Aggressive bullish multi-month reversals followed in both cases. 
  • The 2008 upswing paused when a bearish monthly reversal pattern was delivered in January 2009, but only for 2 months. The bearish monthly reversal pattern in February 2023 appears similar. 

Regional REIT – FY22 DPS covered and yields c 11% yield

By Edison Investment Research

Regional REIT (RGL) has confirmed a Q422 DPS of 1.65p, taking the total for the year to 6.6p. It expects this to be fully covered by EPRA earnings when results are published in March, supported by leasing progress and strong rent collection. Market-wide valuation yield widening reduced NAV and increased gearing, but RGL notes that it has ample headroom available across the debt facilities, which are fixed at a cost of 3.5%.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars